NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
申请人:Zenith Epigenetics Ltd.
公开号:US20170143731A1
公开(公告)日:2017-05-25
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.